Toxoplasma gondii in Cats: Zoonotic Transmission and Feline Clinical Management

Etiology and Life Cycle

Toxoplasma gondii is an obligate intracellular apicomplexan protozoan parasite capable of infecting virtually all warm-blooded vertebrates [1, 2]. The definitive hosts are members of the family Felidae, within which the parasite completes its sexual cycle and produces oocysts [1, 3]. The life cycle comprises both sexual (enteric) and asexual (extraintestinal) phases. Cats become infected through ingestion of tissue cysts containing bradyzoites in intermediate host tissues, ingestion of sporulated oocysts from the environment, or via vertical transmission [2, 4]. Following ingestion, bradyzoites or sporozoites invade the small intestinal epithelium and undergo multiple rounds of asexual replication (schizogony) before differentiating into male and female gametes [1, 2]. Fertilization results in the formation of unsporulated oocysts, which are shed in the feces [1]. This process of oocyst excretion, often referred to as toxoplasmosis in cat poop, is typically transient, lasting 1 to 3 weeks in a naive cat [2, 4]. Shedding can involve millions of oocysts per day, and once sporulated in the environment, oocysts remain infectious for months to years [5, 4].

Epidemiology and Zoonotic Transmission

The seroprevalence of T. gondii in domestic cat populations varies widely by geographic region, lifestyle, and age [6, 7, 8]. A meta-analysis of studies from mainland China reported a pooled seroprevalence of 24.5% in cats sampled between 1995 and 2016 [7]. A subsequent meta-analysis covering 2016 to 2020 found a lower seroprevalence of 19.9%, suggesting a possible temporal decline [6]. In urban pet cats in China, seroprevalence was 4.2%, whereas stray cats showed a significantly higher rate of 20.9% [8]. Similar patterns have been observed globally. In Cyprus, 32.3% of 155 cats were seropositive [9]. In Bangkok, Thailand, seroprevalence in outdoor cats was 18.7% [10]. In Lima, Peru, 11% of cats were seropositive by indirect hemagglutination [11]. In Sweden, seroprevalence in cats was reported at 16.7% [12]. In the metropolitan region of Guadalajara, Mexico, seroprevalence was 14.8% [13]. In Rio de Janeiro, Brazil, 8.1% of domiciled cats were seropositive [14]. In Kerman, Iran, seroprevalence in cats was 28.3% [15]. In Colombo, Sri Lanka, seroprevalence was 30.6% [16]. In Slovakia, a coprological survey of 2261 cats found T. gondii oocysts in 0.4% of samples [17]. In Mashhad, Iran, Toxoplasma-like oocysts were microscopically observed in 2.2% of stray cat fecal samples [18].

Risk factors consistently associated with seropositivity include increasing age, outdoor access, stray or free-roaming lifestyle, hunting behavior, and consumption of raw meat [7, 11, 8, 10, 13, 14, 19]. Age is a significant predictor, with seroprevalence increasing from 17.4% in cats under 1 year to 31.6% in cats over 3 years in one Chinese meta-analysis [7]. Stray cats have approximately three times the odds of seropositivity compared to pet cats [7]. Feeding raw meat or offal is a strong risk factor, with odds ratios of 8.49 for homemade food consumption and 7.66 for offal consumption reported in Brazil [14]. Coinfection with feline immunodeficiency virus (FIV) is associated with T. gondii seropositivity, likely due to immunosuppression [9, 20]. In a study from the Brazilian semiarid region, 75% of FIV-positive cats were also seropositive for T. gondii [20].

Zoonotic transmission occurs primarily through ingestion of sporulated oocysts from contaminated environments (e.g., soil, litter boxes, water) or through consumption of undercooked meat containing tissue cysts [21, 7, 8]. Cats are the only definitive hosts that shed oocysts, making them the primary source of environmental contamination [1, 3]. A study comparing cat-owning and non-cat-owning women found a significantly higher seroprevalence in cat owners (30.0%) compared to non-owners (17.5%), underscoring the role of direct feline contact in human exposure [21].

Clinical Signs and Pathology

Most T. gondii infections in cats are subclinical [22, 23, 24]. Clinical disease is more common in immunocompromised cats, including those coinfected with FIV or feline leukemia virus (FeLV), and in very young kittens [9, 20]. Clinical signs are referable to the organ systems affected by tachyzoite replication and tissue necrosis. The most frequently reported clinical manifestations include fever, lethargy, anorexia, and weight loss [22, 23]. Ocular toxoplasmosis can present as uveitis, chorioretinitis, or anterior chamber inflammation [23]. Neurological signs, such as ataxia, seizures, tremors, and behavioral changes, result from encephalitis or meningoencephalitis [22, 23]. Respiratory signs, including dyspnea and tachypnea, may occur due to interstitial pneumonia [23]. Hepatic involvement can cause icterus and elevated liver enzymes [23]. Pancreatitis and myocarditis are less common but documented sequelae [23]. The pathology of acute toxoplasmosis is characterized by multifocal necrosis and inflammation in affected tissues, with tachyzoites visible within cells or free in tissue sections [22, 23].

Diagnostics

Diagnosis of T. gondii infection in cats relies on a combination of serological, molecular, and coprological methods.

Serological Testing

Serological assays detect antibodies (primarily IgG and IgM) against T. gondii. The modified agglutination test (MAT) is considered a reference standard for serological surveys in cats [25]. A comparison of MAT and indirect hemagglutination test (IHAT) in 89 domestic cats found MAT seroprevalence of 26% and IHAT seroprevalence of 18%, with the IHAT showing 70% sensitivity relative to MAT [25]. Enzyme-linked immunosorbent assays (ELISAs) using recombinant antigens such as GRA7, SAG2, and GRA6 have been developed and evaluated [26, 27]. GRA7-based ELISA demonstrated higher sensitivity than SAG2 or GRA6 for detecting anti-T. gondii antibodies in cats [27]. Immunochromatographic tests (ICTs) using recombinant GRA7 or SAG2 provide rapid, point-of-care serodiagnosis with comparable performance to conventional ELISA [26, 28]. Western blotting is also used for confirmatory serological testing [13]. Indirect immunofluorescence antibody tests (IFAT) are employed in many epidemiological studies [14, 20].

Molecular Detection

Polymerase chain reaction (PCR) targeting the B1 gene or the 529 bp repetitive element is widely used for detecting T. gondii DNA in blood, tissues, and feces [29, 30, 31, 13, 18, 19]. Real-time PCR offers quantitative and highly sensitive detection [29]. Isothermal amplification methods, such as loop-mediated isothermal amplification (LAMP) combined with lateral flow dipsticks (LAMP-LFD), have been developed for field-deployable detection, with a limit of detection of 1 fg of T. gondii DNA [31]. Recombinase polymerase amplification (RPA) coupled with CRISPR/Cas12a and lateral flow assay (RPA-CRISPR/Cas12a-LFA) enables detection within 55 minutes with a limit of 31 copies per microliter of the B1 gene [30]. This method was used to survey stray cats in Zhejiang, China, finding a positive rate of 8.0% [30].

Coprological Examination

Microscopic examination of feces using flotation techniques can identify T. gondii oocysts, but sensitivity is low due to intermittent and transient shedding [21, 11, 17, 18]. Oocysts are morphologically indistinguishable from those of other coccidians, such as Hammondia hammondi, necessitating molecular confirmation [18]. In a study of 175 stray cats in Iran, Toxoplasma-like oocysts were found in 2.2% of samples by microscopy, but only one sample was confirmed by PCR [18]. In Kunming, China, only 1 of 74 fecal samples (1.4%) was PCR-positive despite a seroprevalence of 72.7% [19].

Genotyping

Genotyping of T. gondii isolates from cats reveals a predominance of clonal type II strains in Europe and North America [32, 18]. In Germany, serotyping using peptide microarrays showed that 98.8% of naturally infected cats had antibody patterns consistent with type II infection [32]. In Mashhad, Iran, a type II isolate was obtained from a stray cat brain by mouse bioassay and PCR-RFLP [18]. In Colombia, isolates from cats included types I, II, and III [33].

Treatment

Treatment of clinical toxoplasmosis in cats is indicated when signs of active disease are present. The primary therapeutic regimen consists of clindamycin administered at 10 to 12 mg/kg orally or intramuscularly every 12 hours for 2 to 4 weeks [22, 23]. Alternative antibiotics include trimethoprim-sulfonamide combinations (15 mg/kg every 12 hours) and azithromycin (10 mg/kg every 24 hours) [22, 23]. Supportive care, including fluid therapy, nutritional support, and anti-inflammatory doses of corticosteroids for ocular or neurological inflammation, may be necessary [22, 23]. Treatment does not eliminate tissue cysts, and cats remain latently infected for life [22, 23]. There is no approved therapy to prevent or terminate oocyst shedding, although ponazuril (toltrazuril sulfone) has been used experimentally to reduce shedding [22].

Control and Prevention

Control of T. gondii infection in cats focuses on reducing exposure to the parasite and minimizing environmental contamination. Key preventive measures include:

• Feeding only commercial cooked or processed cat food; avoiding raw meat, offal, or unpasteurized milk [11, 8, 14].
• Preventing hunting behavior through confinement or supervised outdoor access [11, 8].
• Daily removal and proper disposal of feces from litter boxes to prevent oocyst sporulation [21, 5].
• Regular cleaning of litter boxes with hot water (above 70 degrees Celsius) to inactivate oocysts [5].
• Controlling rodent populations around the home to reduce intermediate host exposure [22].
• Routine veterinary health checks and vaccination against FIV and FeLV to reduce immunosuppression [9, 20].

Public health education regarding toxoplasmosis in cat poop is essential for cat owners, particularly pregnant women and immunocompromised individuals [21, 7, 8]. Serological screening of cats is not recommended for assessing human risk, as seropositive cats are unlikely to be actively shedding oocysts [9, 19].

Diagnostic and Management Decision Framework

The following Mermaid diagram outlines a clinical decision pathway for managing a cat suspected of T. gondii infection.

flowchart TD
    A[Cat presents with clinical signs<br>consistent with toxoplasmosis], > B{Serological testing<br>(MAT, ELISA, or ICT)}
    B, >|IgG positive, IgM negative| C[Chronic/latent infection<br>Unlikely to be actively shedding]
    B, >|IgG and IgM positive| D[Recent or active infection<br>Possible shedding]
    B, >|Both negative| E[No serological evidence<br>Consider alternative diagnoses]
    D, > F{Clinical signs present?}
    F, >|Yes| G[Initiate clindamycin therapy<br>Supportive care]
    F, >|No| H[Monitor; no treatment indicated<br>Implement hygiene measures]
    G, > I[Re-evaluate clinical response<br>in 7-14 days]
    I, >|Improvement| J[Complete 2-4 week course]
    I, >|No improvement| K[Reconsider diagnosis<br>Perform PCR or imaging]
    C, > L[No treatment needed<br>Educate owner on prevention]
    E, > M[Investigate other etiologies<br>e.g., FIV, FeLV, other pathogens]

References

[1] Frenkel, J. K., Dubey, J. P., Miller, N. Toxoplasma gondii in Cats: Fecal Stages Identified as Coccidian Oocysts. Science. 1970. https://www.semanticscholar.org/paper/d71bf42a7bfe263c7f5b2d06f5015fba6fd984e3

[2] Dubey, J. TACHYZOITE-INDUCED LIFE CYCLE OF TOXOPLASMA GONDII IN CATS. Journal of Parasitology. 2002. https://www.semanticscholar.org/paper/b76230f3d5bdaad900e88dfdf5d1bbc3517ed337

[3] Erratum: Toxoplasma gondii in Cats: Fecal Stages Identified as Coccidian Oocysts. Science. 1970. https://www.semanticscholar.org/paper/2107bb5121cb5c58225021fd2dde7a58672848b7

[4] Awobode, H., Paul, A., Sengoku-Graham, H., et al. Serial Monoxenous Transmission of Toxoplasma gondii in Cats. Journal of Parasitology. 2013. https://www.semanticscholar.org/paper/45688698bda370651a62f4e17938aa2dd2734450

[5] Afonso, E., Thulliez, P., Gilot-Fromont, E. Local meteorological conditions, dynamics of seroconversion to Toxoplasma gondii in cats (Felis catus) and oocyst burden in a rural environment. Epidemiology and Infection. 2009. https://www.semanticscholar.org/paper/c946e6fe1c5f433e69e53bc687818beac8008dea

[6] Zhou, S., Sang, Z., Wang, L., et al. Seroprevalence of Toxoplasma gondii in cats in mainland China 2016-2020: a meta-analysis. Journal of Veterinary Sciences. 2021. https://www.semanticscholar.org/paper/e4b990f84422d4e235403196e2d7adc858fba5e3

[7] Ding, H., Gao, Y., Deng, Y., et al. A systematic review and meta-analysis of the seroprevalence of Toxoplasma gondii in cats in mainland China. Parasites & Vectors. 2017. https://www.semanticscholar.org/paper/707867d46141d54e461786e27b0d911be73ea024

[8] Xia, N., Ji, N., Li, L., et al. Seroprevalence and risk factors of Toxoplasma gondii in urban cats from China. BMC Veterinary Research. 2022. https://www.semanticscholar.org/paper/fb405e46df8126da1c8172fe0343cfeff8606f6b

[9] Attipa, C., Yiapanis, C., Tasker, S., et al. Seroprevalence of Toxoplasma gondii in Cats from Cyprus. Pathogens. 2021. https://www.semanticscholar.org/paper/2428e1e6e21a05707a16e1cdd3827c4b58f3cc9a

[10] Huertas-López, A., Sukhumavasi, W., Álvarez-García, G., et al. Seroprevalence of Toxoplasma gondii in outdoor dogs and cats in Bangkok, Thailand. Parasitology. 2021. https://www.semanticscholar.org/paper/a198bcb77a9bdff37096fef1d4188e140af38740

[11] Cerro, L., Rubio, A., Pinedo, R., et al. Seroprevalence of Toxoplasma gondii in cats (Felis catus, Linnaeus 1758) living in Lima, Peru. Revista Brasileira de Parasitologia Veterinaria. 2014. https://www.semanticscholar.org/paper/6ab7c74cee33cc4d6a2b6830850a46eff1469b1a

[12] Uggla, A., Mattson, S., Juntti, N. Prevalence of Antibodies to Toxoplasma gondii in Cats, Dogs and Horses in Sweden. Acta Veterinaria Scandinavica. 1989. https://www.semanticscholar.org/paper/5bdc32a98b6dbce8649dbee60d641bf94a7a5751

[13] Galván-Ramírez, M. L., Charles-Niño, C., Pedroza-Roldán, C., et al. Prevalence of Toxoplasma gondii Measured by Western Blot, ELISA and DNA Analysis, by PCR, in Cats of Western Mexico. Pathogens. 2022. https://www.semanticscholar.org/paper/4555ef585cbccbbf4dc7f579d6a99ed0fc120ceb

[14] Arruda, I. F., Millar, P., Barbosa, A., et al. Toxoplasma gondii in domiciled dogs and cats in urban areas of Brazil: risk factors and spatial distribution. Parasite. 2021. https://www.semanticscholar.org/paper/2bde89f5f46d2ca03535c8ae43001a6a3e8ac845

[15] Derakhshan, M., Mousavi, M. Serological survey of antibodies to Toxoplasma gondii in cats, goats, and sheep in Kerman, Iran. Comparative Clinical Pathology. 2014. https://www.semanticscholar.org/paper/00b3eb21bab9b98ab73447bbd18f6a98821f906f

[16] Kulasena, V. A., Rajapakse, R., Rajapakse, R., et al. Seroprevalence of Toxoplasma gondii in Cats from Colombo, Sri Lanka. Journal of Parasitology. 2011. https://www.semanticscholar.org/paper/e8cc2045b3cffc1638c890ee26b1563258a0995b

[17] Antolová, D., Valentová, D., Strišková, K., et al. Prevalence of intestinal parasites in owned and shelter cats in Slovakia and felines from Slovak Zoos: A three-year survey with special focus on Toxoplasma gondii. Current Research in Parasitology and Vector-Borne Diseases. 2025. https://www.semanticscholar.org/paper/9a6a046d62eebf617a6610d46eca817456b28d33

[18] Khodaverdi, M., Razmi, G. Prevalence and genotyping of Toxoplasma gondii in stray cats in Mashhad area, Iran. BMC Veterinary Research. 2019. https://www.semanticscholar.org/paper/b31902fb80060675b309c6ce52f2ea28f04b5a87

[19] Yang, C., Liu, S., Tao, C., et al. Serological and molecular survey of Toxoplasma gondii infection and associated risk factors in urban cats in Kunming, Southwest China. Frontiers in Veterinary Science. 2024. https://www.semanticscholar.org/paper/29d8d365ef5aec09d354db61a3e536d0a642b3bd

[20] Feitosa, T., Costa, F. T. R., Ferreira, L. C., et al. High rate of feline immunodeficiency virus infection in cats in the Brazilian semiarid region: Occurrence, associated factors and coinfection with Toxoplasma gondii and feline leukemia virus. Comparative Immunology, Microbiology & Infectious Diseases. 2021. https://www.semanticscholar.org/paper/e7f265e5953910a9dc252c850c094e0e05ed0081

[21] Khayat, F. A. Detection of Toxoplasma Gondii in Cats and Seroprevalence in Women. Indian Journal of Veterinary Sciences & Biotechnology. 2022. https://www.semanticscholar.org/paper/6d65e09ff28416c75071dbd6bacf674eca5a0068

[22] DeFeo, M. L., Dubey, J., Mather, T., et al. Epidemiologic investigation of seroprevalence of antibodies to Toxoplasma gondii in cats and rodents. American Journal of Veterinary Research. 2002. https://www.semanticscholar.org/paper/0a6573de3d60fd1cac4140b9d976a24b3dd7d2b6

[23] Hsu, V., Grant, D., Zajac, A., et al. Prevalence of IgG antibodies to Encephalitozoon cuniculi and Toxoplasma gondii in cats with and without chronic kidney disease from Virginia. Veterinary Parasitology. 2011. https://www.semanticscholar.org/paper/217fb90da1912d5c3d3d83f33ef4a37fe5373506

[24] Svobodová, V., Knotek, Z., Svoboda, M. Prevalence of IgG and IgM antibodies specific to Toxoplasma gondii in cats. Veterinary Parasitology. 1998. https://www.semanticscholar.org/paper/2c5ac51e2eb152df4b153df8a429b64088b45fee

[25] Fernandes, S. M., Brilhante-Simões, P., Coutinho, T., et al. Comparison of indirect and modified agglutination tests for detection of antibodies to Toxoplasma gondii in domestic cats. Journal of Veterinary Diagnostic Investigation. 2019. https://www.semanticscholar.org/paper/c1460c70c177abfb5ed6a9baebed5

[26] Ybañez, R. H., Kyan, H., Nishikawa, Y. Detection of antibodies against Toxoplasma gondii in cats using an immunochromatographic test based on GRA7 antigen. Journal of Veterinary Medical Science. 2020. https://www.semanticscholar.org/paper/b728e27491bbb5242419882d21380d8ab4b80073

[27] Sabukunze, S., Gu, H., Zhao, L., et al. Comparison of the performance of SAG2, GRA6, and GRA7 for serological diagnosis of Toxoplasma gondii infection in cats. Frontiers in Veterinary Science. 2024. https://www.semanticscholar.org/paper/9f5d168c43119aed8d92f0b3115eb05d8db3dc99

[28] Huang, X., Xuan, X., Hirata, H., et al. Rapid Immunochromatographic Test Using Recombinant SAG2 for Detection of Antibodies against Toxoplasma gondii in Cats. Journal of Clinical Microbiology. 2004. https://www.semanticscholar.org/paper/c18123c47f31d49dcc4ddd78138ee55c8d51245d

[29] Montoya, A., Miró, G., Mateo, M., et al. Detection of Toxoplasma gondii in cats by comparing bioassay in mice and polymerase chain reaction (PCR). Veterinary Parasitology. 2009. https://www.semanticscholar.org/paper/462fa6f827257b21d0bce2f40f797b95e3946f41

[30] Sun, H., Fan, J., Chu, H., et al. RPA-CRISPR/Cas12a-LFA combined with a digital visualization instrument to detect Toxoplasma gondii in stray dogs and cats in Zhejiang province, China. Microbiology Spectrum. 2024. https://www.semanticscholar.org/paper/f6dffc0f62f24e2b88a7d9c25876eb0ea43eefc6

[31] Xue, Y., Kong, Q., Ding, H., et al. A novel loop-mediated isothermal amplification-lateral-flow-dipstick (LAMP-LFD) device for rapid detection of Toxoplasma gondii in the blood of stray cats and dogs. Parasite. 2021. https://www.semanticscholar.org/paper/7e5cf611aa0031a66a6e69170b21f32325a6e307

[32] Maksimov, P., Zerweck, J., Dubey, J., et al. Serotyping of Toxoplasma gondii in Cats (Felis domesticus) Reveals Predominance of Type II Infections in Germany. PLoS ONE. 2013. https://www.semanticscholar.org/paper/908aa794b2b085adb57f5fe7a46fb23ce4675d93

[33] Dubey, J., Su, C., Côrtes, J. A., et al. Prevalence of Toxoplasma gondii in cats from Colombia, South America and genetic characterization of T. gondii isolates. Veterinary Parasitology. 2006. https://www.semanticscholar.org/paper/bf3bad1e425590a8f81e93aa8b63bc0d91817621

[34] Erkılıç, Babür, C., Kırmızıgül, A. H., et al. Seroprevalence of Toxoplasma gondii in Cats The Seroprevalence of Toxoplasma gondii in Cats from the Kars Region, Turkey. 2016. https://www.semanticscholar.org/paper/9d84851c1dad35e25b3c31ab8ac9678dab68f7df

[35] Bennett, A. D., Gunn-Moore, D., Brewer, M., et al. Prevalence of Bartonella species, haemoplasmas and Toxoplasma gondii in cats in Scotland. Journal of Feline Medicine and Surgery. 2011. https://www.semanticscholar.org/paper/998008087d5e2c01bf95fa88f10d1534ea2a53a5